Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells

Journal of Experimental Medicine

Volumn 206, Issue 12, 2009, Pages 2701-2715

  Klunker, Sven ^a   Chong, Mark M W ^b   Mantel, Pierre Yves ^a,c   Palomares, Oscar ^a   Bassin, Claudio ^a   Ziegler, Mario ^a   Rückert, Beate ^a   Meiler, Flurina ^a   Akdis, Mübeccel ^a   Littman, Dan R ^b   Akdis, Cezmi A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; CBFB PROTEIN, HUMAN; CBFB PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; FOXP3 PROTEIN, MOUSE; RUNX1 PROTEIN, HUMAN; RUNX1 PROTEIN, MOUSE; RUNX3 PROTEIN, HUMAN; RUNX3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOTRANSFORMATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL TRANSFER; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TONSIL; ANIMAL; CELL DIFFERENTIATION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; MOUSE MUTANT; PALATINE TONSIL; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; FORKHEAD TRANSCRIPTION FACTORS; GENE SILENCING; HUMANS; IMMUNE TOLERANCE; MICE; MICE, KNOCKOUT; PALATINE TONSIL; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 73349115263     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090596     Document Type: Article

References (59)

1. Akdis, C.A. 2006. Allergy and hypersensitivity: mechanisms of allergic disease. Curr. Opin. Immunol. 18:718-726. doi:10.1016/j.coi.2006.09.016
2. Akdis, M., S. Klunker, M. Schliz, K. Blaser, and C.A. Akdis. 2000. Expression of cutaneous lymphocyte-associated antigen on human CD4(+) and CD8(+) Th2 cells. Eur. J. Immunol. 30:3533-3541. doi:10.1002/1521-4141(2000012) 30:12〈3533::AID-IMMU3533〉3.0.CO;2-5
3. Alarcón-Riquelme, M.E. 2003. A RUNX trio with a taste for autoimmunity. Nat. Genet. 35:299-300. doi:10.1038/ng1203-299
4. Bettelli, E., M. Dastrange, and M. Oukka. 2005. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA. 102:5138-5143. doi:10.1073/pnas.0501675102
5. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238. doi:10.1038/nature04753
6. Biggs, J.R., L.F. Peterson, Y. Zhang, A.S. Kraft, and D.E. Zhang. 2006. AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Mol. Cell. Biol. 26:7420-7429. doi:10.1128/MCB.00597-06
7. Blyth, K., E.R. Cameron, and J.C. Neil. 2005. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer. 5:376-387. doi:10.1038/nrc1607
8. Brenner, O., D. Levanon, V. Negreanu, O. Golubkov, O. Fainaru, E. Woolf, and Y. Groner. 2004. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. USA. 101:16016-16021. doi:10.1073/pnas.0407180101
9. Burgler, S., N. Ouaked, C. Bassin, T.M. Basinski, P.Y. Mantel, K. Siegmund, N. Meyer, C.A. Akdis, and C.B. Schmidt-Weber. 2009. Differentiation and functional analysis of human T(H)17 cells. J. Allergy Clin. Immunol. 123:588-595. doi:10.1016/j.jaci.2008.12.017
10. Djuretic, I.M., D. Levanon, V. Negreanu, Y. Groner, A. Rao, and K.M. Ansel. 2007. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8:145-153. doi:10.1038/ni1424
11. Dolganov, G., S. Bort, M. Lovett, J. Burr, L. Schubert, D. Short, M. McGurn, C. Gibson, and D.B. Lewis.1996.Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood. 87:3316-3326.
12. Egawa, T., R.E. Tillman, Y. Naoe, I. Taniuchi, and D.R. Littman. 2007. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204:1945-1957. doi:10.1084/jem.20070133
13. Fainaru, O., D. Shseyov, S. Hantisteanu, and Y. Groner. 2005. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc. Natl. Acad. Sci. USA. 102:10598-10603. doi:10.1073/pnas.0504787102
14. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky.2003.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330-336. doi:10.1038/ni904
15. Helms, C., L. Cao, J.G. Krueger, E.M. Wijsman, F. Chamian, D. Gordon, M. Heffernan, J.A. Daw, J. Robarge, J. Ott, et al. 2003. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 35:349-356. doi:10.1038/ng1268
16. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061. doi:10.1126/science.1079490
17. Hu, H., I. Djuretic, M.S. Sundrud, and A. Rao. 2007. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol. 28:329-332. doi:10.1016/j.it.2007.06.006
18. Inoue, K., S. Ozaki, T. Shiga, K. Ito, T. Masuda, N. Okado, T. Iseda, S. Kawaguchi, M. Ogawa, S.C. Bae, et al. 2002. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5:946-954. doi:10.1038/nn925
19. Ito, Y. 1999. Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF. Genes Cells. 4:685-696. doi:10.1046/j.1365-2443.1999.00298.x
20. Ito, Y., and K. Miyazono. 2003. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr. Opin. Genet. Dev. 13:43-47. doi:10.1016/S0959-437X(03)00007-8
21. Ji, C., O. Eickelberg, T.L. McCarthy, and M. Centrella. 2001. Control and counter-control of TGF-beta activity through FAST and Runx (CBFa) transcriptional elements in osteoblasts. Endocrinology. 142:3873-3879. doi:10.1210/en.142.9.3873
22. Jin, Y.H., E.J. Jeon, Q.L. Li, Y.H. Lee, J.K. Choi, W.J. Kim, K.Y. Lee, and S.C. Bae. 2004. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J. Biol. Chem. 279:29409-29417. doi:10.1074/jbc.M313120200
23. Kang, S.G., H.W. Lim, O.M. Andrisani, H.E. Broxmeyer, and C.H. Kim. 2007. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179:3724-3733.
24. Kehrl, J.H., L.M. Wakefield, A.B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M.B. Sporn, and A.S. Fauci. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050. doi:10.1084/jem.163.5.1037
25. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:755-764. doi:10.1016/S0092-8674(00)80258-5
26. Levanon, D., D. Bettoun, C. Harris-Cerruti, E. Woolf, V. Negreanu, R. Eilam, Y. Bernstein, D. Goldenberg, C. Xiao, M. Fliegauf, et al. 2002. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21:3454-3463. doi:10.1093/emboj/cdf370
27. Look, A.T. 1997.Oncogenic transcription factors in the human acute leukemias. Science. 278:1059-1064. doi:10.1126/science.278.5340.1059
28. Mantel, P.Y., N. Ouaked, B. Rückert, C. Karagiannidis, R. Welz, K. Blaser, and C.B. Schmidt-Weber. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176:3593-3602.
29. Mantel, P.Y., H. Kuipers, O. Boyman, C. Rhyner, N. Ouaked, B. Rückert, C. Karagiannidis, B.N. Lambrecht, R.W. Hendriks, R. Crameri, et al. 2007. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5:e329. doi:10.1371/journal.pbio.0050329
30. +regulatory T cells. J. Exp. Med. 201:1061-1067. doi:10.1084/jem.20042276
31. Maynard, C.L., L.E. Harrington, K.M. Janowski, J.R. Oliver, C.L. Zindl, A.Y. Rudensky, and C.T. Weaver. 2007. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 8:931-941. doi:10.1038/ni1504
32. Meiler, F., J. Zumkehr, S. Klunker, B. Rückert, C.A. Akdis, and M. Akdis. 2008. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 205:2887-2898. doi:10.1084/jem.20080193
33. Miyazawa, K., M. Shinozaki, T. Hara, T. Furuya, and K. Miyazono. 2002. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells. 7:1191-1204. doi:10.1046/j.1365-2443.2002.00599.x
34. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science.317:256-260. doi:10.1126/science. 1145697
35. Naoe, Y., R. Setoguchi, K. Akiyama, S. Muroi, M. Kuroda, F. Hatam, D.R. Littman, and I. Taniuchi. 2007. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf β binding to the Il4 silencer. J. Exp. Med. 204:1749-1755. doi:10.1084/jem.20062456
36. Nelson, J.D., O. Denisenko, and K. Bomsztyk. 2006. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 1:179-185. doi:10.1038/nprot.2006.27
37. Ono, M., H. Yaguchi, N. Ohkura, I. Kitabayashi, Y. Nagamura, T. Nomura, Y. Miyachi, T. Tsukada, and S. Sakaguchi. 2007. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature. 446:685-689. doi:10.1038/nature05673
38. Otto, F., M. Lübbert, and M. Stock. 2003. Upstream and downstream targets of RUNX proteins. J. Cell. Biochem. 89:9-18. doi:10.1002/jcb. 10491
39. Prokunina, L., C. Castillejo-López, F. Oberg, I. Gunnarsson, L. Berg, V. Magnusson, A.J. Brookes, D. Tentler, H. Kristjansdóttir, G. Gröndal, et al. 2002. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32:666-669. doi:10.1038/ng1020
40. Rubtsov, Y.P., and A.Y. Rudensky. 2007. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7:443-453. doi:10.1038/nri2095
41. Rudra, D., T. Egawa, M.M. Chong, P. Treuting, D.R. Littman, and A.Y. Rudensky. 2009. Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10:1170-1177.
42. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immuno-logic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562. doi:10.1146/annurev.immunol.21.120601.141122
43. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell. 133:775-787. doi:10.1016/j.cell.2008. 05.009
44. Schubert, L.A., E. Jeffery, Y. Zhang, F. Ramsdell, and S.F. Ziegler. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276:37672-37679. doi:10.1074/jbc.M104521200
45. Siegel, P.M., and J. Massagué. 2003. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer. 3:807-821. doi:10.1038/nrc1208
46. Sun, C.M., J.A. Hall, R.B. Blank, N. Bouladoux, M. Oukka, J.R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-1785. doi:10.1084/jem.20070602
47. Taniuchi, I., M. Osato, T. Egawa, M.J. Sunshine, S.C. Bae, T. Komori, Y. Ito, and D.R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 111:621-633. doi:10.1016/S0092-8674(02)01111-X
48. Tokuhiro, S., R. Yamada, X. Chang, A. Suzuki, Y. Kochi, T. Sawada, M. Suzuki, M. Nagasaki, M. Ohtsuki, M. Ono, et al. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341-348. doi:10.1038/ng1267
49. Tone, Y., K. Furuuchi, Y. Kojima, M.L. Tykocinski, M.I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9:194-202. doi:10.1038/ni1549
50. Verhagen, J., M. Akdis, C. Traidl-Hoff mann, P. Schmid-Grendelmeier, D. Hijnen, E.F. Knol, H. Behrendt, K. Blaser, and C.A. Akdis. 2006. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J. Allergy Clin. Immunol. 117:176-183. doi:10.1016/j.jaci.2005.10.040
51. Wang, S., Q. Wang, B.E. Crute, I.N. Melnikova, S.R. Keller, and N.A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324-3339.
52. Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A.H. Sharpe, and N.A. Speck. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA. 93:3444-3449. doi:10.1073/pnas.93.8.3444
53. Wei, J., O. Duramad, O.A. Perng, S.L. Reiner, Y.J. Liu, and F.X. Qin. 2007. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 104:18169-18174. doi:10.1073/pnas.0703642104
54. Williams, L.M., and A.Y. Rudensky.2007.Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8:277-284. doi:10.1038/ni1437
55. Wu, Y., M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, J.C. Stroud, D.L. Bates, L. Guo, A. Han, S.F. Ziegler, et al. 2006. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 126:375-387. doi:10.1016/j.cell.2006.05.042
56. Yamamura, Y., W.L. Lee, K. Inoue, H. Ida, and Y. Ito. 2006. RUNX3 cooperates with FoxO3a to induce apoptosis in gastric cancer cells. J. Biol. Chem. 281:5267-5276. doi:10.1074/jbc.M512151200
57. Zhang, F., G. Meng, and W. Strober. 2008. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9:1297-1306. doi:10.1038/ni.1663
58. Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 453:236-240. doi:10.1038/nature06878
59. Ziegler, S.F. 2006.FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-226. doi:10.1146/annurev.immunol.24.021605.090547